secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001493152-23-020669
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio CEO gets pay raise; shareholders OK equity plan amendments increasing shares
--------------------------------------------------------------------------------

- CEO J.D. Finley's base salary raised to $542,000 from $490,000; bonus target increased to 50% from 45%, effective June 1, 2023.
- Committee approved 245,660 employee options and 112,030 RSUs; each of 7 directors gets 5,160 options or 2,580 options plus 1,880 RSUs.
- Shareholders approved 2021 Equity Incentive Plan amendment, increasing authorized shares by 708,072 and annual evergreen to 7.5% from 4%.
- Shareholders also approved 2021 ESPP amendment, adding 109,944 shares and raising annual increase to 2.5% from 1%.
- Annual meeting elected directors Neal, Finley, Gray as Class III directors to 2026; all other proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315223020669/0001493152-23-020669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315223020669/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer